These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35914122)
1. Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years. Yin JK; Pepin S; van Aalst R; Loiacono MM; Samson SI Hum Vaccin Immunother; 2022 Nov; 18(6):2106749. PubMed ID: 35914122 [TBL] [Abstract][Full Text] [Related]
2. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602 [TBL] [Abstract][Full Text] [Related]
3. [Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China]. Zhang T; Bai XF; Wang W; Liu XX; Zhang XX; Wang DY; Zhang SB; Chen ZP; He HQ; Huang ZY; Xu AQ; Peng ZB; Feng LZ; Yu WZ; Feng Z Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):103-107. PubMed ID: 34954956 [TBL] [Abstract][Full Text] [Related]
4. Letter to the editor: Increase of influenza vaccination coverage rates during the COVID-19 pandemic and implications for the upcoming influenza season in northern hemisphere countries and Australia. Del Riccio M; Lina B; Caini S; Staadegaard L; Wiegersma S; Kynčl J; Combadière B; MacIntyre CR; Paget J Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915972 [No Abstract] [Full Text] [Related]
5. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607 [TBL] [Abstract][Full Text] [Related]
6. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use. Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P; Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551 [TBL] [Abstract][Full Text] [Related]
7. Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies. Janssen C; Mosnier A; Gavazzi G; Combadière B; Crépey P; Gaillat J; Launay O; Botelho-Nevers E Hum Vaccin Immunother; 2022 Nov; 18(6):2131166. PubMed ID: 36256633 [TBL] [Abstract][Full Text] [Related]
8. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)]. National Immunization Advisory Committee Technical Working Group Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228 [TBL] [Abstract][Full Text] [Related]
9. Reply letter to "Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design". Hadigal S; Colombo L; Haughie S Hum Vaccin Immunother; 2023 Aug; 19(2):2227034. PubMed ID: 37344371 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of SARS-CoV-2 vaccination resulting from the COVID-19 pandemic with regard to the uptake of influenza virus, pneumococcal, and herpes zoster adult vaccination - a narrative literature review. Kłoda K; Mierzecki A; Mastalerz-Migas A; Babicki M Ann Agric Environ Med; 2023 Dec; 30(4):587-594. PubMed ID: 38153058 [TBL] [Abstract][Full Text] [Related]
11. Reply letter to "Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial". Hadigal S; Colombo L; Haughie S Hum Vaccin Immunother; 2022 Nov; 18(5):2085470. PubMed ID: 35674507 [TBL] [Abstract][Full Text] [Related]
12. To Vaccinate or not to Vaccinate; That is the Question! (New Insights into COVID-19 Vaccination). El-Nakeep S Curr Mol Med; 2022; 22(7):567-571. PubMed ID: 33982651 [TBL] [Abstract][Full Text] [Related]
13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484 [TBL] [Abstract][Full Text] [Related]
14. Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach. Majeed B; David JF; Bragazzi NL; McCarthy Z; Grunnill MD; Heffernan J; Wu J; Woldegerima WA Front Public Health; 2022; 10():1086849. PubMed ID: 36684896 [TBL] [Abstract][Full Text] [Related]
15. The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing. Song Z; Liu X; Xiang P; Lin Y; Dai L; Guo Y; Liao J; Chen Y; Liang Y; Sun Y Int J Chron Obstruct Pulmon Dis; 2021; 16():3337-3346. PubMed ID: 34949917 [TBL] [Abstract][Full Text] [Related]
16. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232 [TBL] [Abstract][Full Text] [Related]
17. Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations. Loubet P; Sotto A; Hum Vaccin Immunother; 2021 Oct; 17(10):3472-3473. PubMed ID: 34097564 [TBL] [Abstract][Full Text] [Related]
18. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1555-1576. PubMed ID: 33297613 [TBL] [Abstract][Full Text] [Related]
19. Parents' intent to vaccinate against influenza during the COVID-19 pandemic im two regions in Switzerland. Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 35275392 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study. Izikson R; Brune D; Bolduc JS; Bourron P; Fournier M; Moore TM; Pandey A; Perez L; Sater N; Shrestha A; Wague S; Samson SI Lancet Respir Med; 2022 Apr; 10(4):392-402. PubMed ID: 35114141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]